Target intelligence / Profile preview

Reactive oxygen species and oxidized cellular components (ROS)

Target
ROS
Molecular classification
Reactive molecules, Free radicals, Oxidized lipids, Oxidized proteins, Oxidized nucleic acids
01

Overview

Reactive oxygen species (ROS) are highly reactive oxygen-containing molecules, including free radicals like superoxide and non-radicals like hydrogen peroxide, which are natural byproducts of cellular metabolism (StatPearls, 2023). While they play critical roles in cell signaling and host defense, an imbalance between ROS production and antioxidant defenses leads to oxidative stress, resulting in the damage of cellular components such as lipids, proteins, and DNA (NIH, 2022). These oxidized cellular components, such as oxidized LDL or carbonylated proteins, often serve as pathological drivers in various diseases including atherosclerosis and neurodegeneration (PubMed, 2021). Therapeutically, ROS and their oxidized products are targeted by antioxidant scavengers and reducing agents to mitigate tissue damage (PubChem, 2024). However, targeting ROS is challenging due to their dual role in essential physiological signaling processes, where excessive suppression can lead to reductive stress (Wikipedia, 2024). This entry is considered incorrect as a specific therapeutic target because it represents a broad class of reactive chemicals and damaged byproducts rather than a single, discrete molecular entity or protein (UniProt, 2024).

Other names
Free radicalsOxidantsReactive oxygen speciesOxidized macromoleculesReactive nitrogen species (RNS)Oxidative stress markers
02

Mechanism of action

The primary mechanism involves the direct chemical neutralization or scavenging of free radicals and reactive species, thereby preventing the oxidation of vital cellular macromolecules (PubMed, 2020). Some agents act as sacrificial targets or electron donors to reduce already oxidized components, such as lipid peroxides, back to their stable forms (StatPearls, 2023).

03

Biological functions

Signal transductionImmune responseApoptosisCell deathRedox regulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesAging
05

Safety considerations

Disruption of essential redox-sensitive signaling pathways (PubMed, 2019)Potential pro-oxidant effects at high concentrations (NIH, 2021)Reductive stressPoor clinical translation of non-specific scavengers
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Protein carbonylsF2-isoprostanesGlutathione/Glutathione disulfide (GSH/GSSG) ratio

Beyond the preview

Go deeper on Reactive oxygen species and oxidized cellular components (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and oxidized cellular components (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call